Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non–Small Cell Lung Carcinoma-Reference-Cited by-同舟云学术

Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non–Small Cell Lung Carcinoma

Published:2017-05 Issue:3 Volume:19 Page:404-416
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Mellert Hestia,Foreman Trudi,Jackson Leisa,Maar Dianna,Thurston Scott,Koch Kristina,Weaver Amanda,Cooper Samantha,Dupuis Nicholas,Sathyanarayana Ubaradka G.,Greer Jakkie,Hahn Westen,Shelton Dawne,Stonemetz Paula,Pestano Gary A.

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference50 articles.

1. Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays;Weber;BMC Cancer [Internet],2014

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci U S A,2004

5. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat Rev Cancer,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of EGFR T790M mutation using liquid biopsy for non-small cell lung cancer: Utility of droplet digital polymerase chain reaction vs. cobas real-time polymerase chain reaction;Pathology - Research and Practice;2024-03

2. Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First‐Line Mutant Epidermal Growth Factor Receptor Non‐Small Cell Lung Cancer;Clinical Pharmacology & Therapeutics;2023-12-21

3. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy;Journal of Hepato-Biliary-Pancreatic Sciences;2023-10-27

4. Detection of KRAS mutation using plasma samples in non-small-cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-07-06

5. Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities;Journal of Clinical Oncology;2023-01-01